Figures & data
Figure 1. Testing of spatial learning and memory in the AD+TG, AD+donepezil, AD model and Normal control groups by Morris water maze. (a) The swimming trajectory of mice in the Normal control group; (b) The swimming trajectory of mice in the AD model group; (c) The swimming trajectory of mice in the AD+donepezil group; (d) The swimming trajectory of mice in the AD+TG group; (e) Significant difference of escape latency in the AD+TG group than that in the AD model group was detected (** p < 0.05). (f) Significant more frequency of crossing the target platform in AD+TG group than that in the AD model group was detected (** p < 0.05). Data was expressed as the mean ± standard error of the mean (SEM). (n = 8/group in the AD+TG group; n = 8/group in the AD+donepezil group; n = 8/group in the AD model group; n = 8/group in the Normal control group). ‘**’ indicating significant inter-group difference. TG: Tripterygium glycoside; AD: Alzheimer disease; NS: normal saline
![Figure 1. Testing of spatial learning and memory in the AD+TG, AD+donepezil, AD model and Normal control groups by Morris water maze. (a) The swimming trajectory of mice in the Normal control group; (b) The swimming trajectory of mice in the AD model group; (c) The swimming trajectory of mice in the AD+donepezil group; (d) The swimming trajectory of mice in the AD+TG group; (e) Significant difference of escape latency in the AD+TG group than that in the AD model group was detected (** p < 0.05). (f) Significant more frequency of crossing the target platform in AD+TG group than that in the AD model group was detected (** p < 0.05). Data was expressed as the mean ± standard error of the mean (SEM). (n = 8/group in the AD+TG group; n = 8/group in the AD+donepezil group; n = 8/group in the AD model group; n = 8/group in the Normal control group). ‘**’ indicating significant inter-group difference. TG: Tripterygium glycoside; AD: Alzheimer disease; NS: normal saline](/cms/asset/4bdda08f-1a0f-4c45-ae8c-b5781ef31c52/kbie_a_1987082_f0001_oc.jpg)
Figure 2. The distribution of Aβ, p-Tau and CD11b immunolabeling across the brains in the AD+TG, AD+donepezil, AD model and Normal control groups. (a–e): The distribution of Aβ immunolabeling in the AD+TG, AD+donepezil, AD model and Normal control groups. (f–j): The distribution of p-Tau immunolabeling in the AD+TG, AD+donepezil, AD model and Normal control groups. (k–o): The distribution of CD11b immunolabeling in the AD+TG, AD+donepezil, AD model and Normal control groups. Data was expressed as the mean ± standard error of the mean (SEM). (n = 8/group in the AD+TG group; n = 8/group in the AD+donepezil group; n = 8/group in the AD model group; n = 8/group in the Normal control group). ‘**’ indicating significant inter-group difference. TG: Tripterygium glycoside; AD: Alzheimer disease; NS: normal saline
![Figure 2. The distribution of Aβ, p-Tau and CD11b immunolabeling across the brains in the AD+TG, AD+donepezil, AD model and Normal control groups. (a–e): The distribution of Aβ immunolabeling in the AD+TG, AD+donepezil, AD model and Normal control groups. (f–j): The distribution of p-Tau immunolabeling in the AD+TG, AD+donepezil, AD model and Normal control groups. (k–o): The distribution of CD11b immunolabeling in the AD+TG, AD+donepezil, AD model and Normal control groups. Data was expressed as the mean ± standard error of the mean (SEM). (n = 8/group in the AD+TG group; n = 8/group in the AD+donepezil group; n = 8/group in the AD model group; n = 8/group in the Normal control group). ‘**’ indicating significant inter-group difference. TG: Tripterygium glycoside; AD: Alzheimer disease; NS: normal saline](/cms/asset/df891dc1-6526-482c-82e1-87326db4249a/kbie_a_1987082_f0002_oc.jpg)
Figure 3. The results of Nissl staining. (a) Nissl staining in the Normal control group. (b) Nissl staining in the AD model group. (c) Nissl staining in the AD+donepezil group. (d) Nissl staining in the AD+TG group. (e) The comparison of the number of pyramidal neurons in the AD+TG, AD+donepezil, AD model and Normal control groups. Data was expressed as the mean ± standard error of the mean (SEM). (n = 8/group in the AD+TG group; n = 8/group in the AD+donepezil group; n = 8/group in the AD model group; n = 8/group in the Normal control group). ‘**’ indicating significant inter-group difference. TG: Tripterygium glycoside; AD: Alzheimer disease; NS: normal saline
![Figure 3. The results of Nissl staining. (a) Nissl staining in the Normal control group. (b) Nissl staining in the AD model group. (c) Nissl staining in the AD+donepezil group. (d) Nissl staining in the AD+TG group. (e) The comparison of the number of pyramidal neurons in the AD+TG, AD+donepezil, AD model and Normal control groups. Data was expressed as the mean ± standard error of the mean (SEM). (n = 8/group in the AD+TG group; n = 8/group in the AD+donepezil group; n = 8/group in the AD model group; n = 8/group in the Normal control group). ‘**’ indicating significant inter-group difference. TG: Tripterygium glycoside; AD: Alzheimer disease; NS: normal saline](/cms/asset/0eff4710-a6f0-4613-b3e4-ceac56691a92/kbie_a_1987082_f0003_oc.jpg)
Figure 4. The expression levels of p-P38, P38, p-IκBα, Caspase1, COX2, and iNOS proteins between groups. Quantitative summaries of the protein levels relative to α-tubulin as an internal control, expressed as a percentage of α-tubulin optical density (o.d.) for the groups (n = 8/group). Statistical results (Kruskal–Wallis nonparametric test with Dunn’s multiple post hoc comparison) were shown in the bar graphs, with ‘**’ indicating significant inter-group difference. Data was expressed as the mean ± standard error of the mean (SEM)(n = 8/group). (a–g) The expression levels of p-P38, P38, p-IκBα, Caspase1, COX2, and iNOS proteins in AD+TG, AD+donepezil, AD mice model and Normal control groups. (a) p-P38; (b) P38; (c) p-IκBα; (d) Caspase1; (e) COX2; (f) iNOS. (g) The western blotting results of p-P38, P38, p-IκBα, Caspase1, COX2, and iNOS proteins. (h–n) The expression levels of p-P38, P38, p-IκBα, Caspase1, COX2, and iNOS proteins in AD+TG, AD cell model and Normal control groups. (h) p-P38; (i) P38; (j) p-IκBα; (k) Caspase1; (l) COX2; (m) iNOS. (n) The western blotting results of p-P38, P38, p-IκBα, Caspase1, COX2, and iNOS proteins. ‘**’ indicating significant inter-group difference. TG: Tripterygium glycoside; AD: Alzheimer disease; NS: normal saline
![Figure 4. The expression levels of p-P38, P38, p-IκBα, Caspase1, COX2, and iNOS proteins between groups. Quantitative summaries of the protein levels relative to α-tubulin as an internal control, expressed as a percentage of α-tubulin optical density (o.d.) for the groups (n = 8/group). Statistical results (Kruskal–Wallis nonparametric test with Dunn’s multiple post hoc comparison) were shown in the bar graphs, with ‘**’ indicating significant inter-group difference. Data was expressed as the mean ± standard error of the mean (SEM)(n = 8/group). (a–g) The expression levels of p-P38, P38, p-IκBα, Caspase1, COX2, and iNOS proteins in AD+TG, AD+donepezil, AD mice model and Normal control groups. (a) p-P38; (b) P38; (c) p-IκBα; (d) Caspase1; (e) COX2; (f) iNOS. (g) The western blotting results of p-P38, P38, p-IκBα, Caspase1, COX2, and iNOS proteins. (h–n) The expression levels of p-P38, P38, p-IκBα, Caspase1, COX2, and iNOS proteins in AD+TG, AD cell model and Normal control groups. (h) p-P38; (i) P38; (j) p-IκBα; (k) Caspase1; (l) COX2; (m) iNOS. (n) The western blotting results of p-P38, P38, p-IκBα, Caspase1, COX2, and iNOS proteins. ‘**’ indicating significant inter-group difference. TG: Tripterygium glycoside; AD: Alzheimer disease; NS: normal saline](/cms/asset/e37fd0e0-5329-4c82-9733-811a1ba0a466/kbie_a_1987082_f0004_b.gif)
Figure 5. The expression levels of IL-1β, TNF-α, COX2, and iNOS mRNAs between groups. (a) The expression levels of IL-1β, TNF-α, COX2, and iNOS mRNAs in brain tissues in the AD+TG, AD+donepezil, AD model and Normal control groups. (b) The expression levels of IL-1β, TNF-α, COX2, and iNOS mRNAs in the AD+TG, AD cell model and Normal control groups. Data was expressed as the mean ± standard error of the mean (SEM)(n = 8/group). ‘**’ indicating significant inter-group difference. TG: Tripterygium glycoside; AD: Alzheimer disease; NS: normal saline
![Figure 5. The expression levels of IL-1β, TNF-α, COX2, and iNOS mRNAs between groups. (a) The expression levels of IL-1β, TNF-α, COX2, and iNOS mRNAs in brain tissues in the AD+TG, AD+donepezil, AD model and Normal control groups. (b) The expression levels of IL-1β, TNF-α, COX2, and iNOS mRNAs in the AD+TG, AD cell model and Normal control groups. Data was expressed as the mean ± standard error of the mean (SEM)(n = 8/group). ‘**’ indicating significant inter-group difference. TG: Tripterygium glycoside; AD: Alzheimer disease; NS: normal saline](/cms/asset/8b71e51f-6976-4623-90fa-c69621ef4363/kbie_a_1987082_f0005_b.gif)
Figure 6. The expression levels of IL-1β, TNF-α and release of NO between groups. A: The expression levels of IL-1β, TNF-α and release of NO in the AD+TG, AD+donepezil, AD model and Normal control groups. (a) IL-1β; (b) TNF-α; (c) Nitrite. B: The expression levels of IL-1β, TNF-α and release of NO in the AD+TG, AD cell model and Normal control groups. (d) IL-1β; (e) TNF-α; (f) Nitrite.Data was expressed as the mean ± standard error of the mean (SEM)(n = 8/group). ‘**’ indicating significant inter-group difference. TG: Tripterygium glycoside; AD: Alzheimer disease; NS: normal saline
![Figure 6. The expression levels of IL-1β, TNF-α and release of NO between groups. A: The expression levels of IL-1β, TNF-α and release of NO in the AD+TG, AD+donepezil, AD model and Normal control groups. (a) IL-1β; (b) TNF-α; (c) Nitrite. B: The expression levels of IL-1β, TNF-α and release of NO in the AD+TG, AD cell model and Normal control groups. (d) IL-1β; (e) TNF-α; (f) Nitrite.Data was expressed as the mean ± standard error of the mean (SEM)(n = 8/group). ‘**’ indicating significant inter-group difference. TG: Tripterygium glycoside; AD: Alzheimer disease; NS: normal saline](/cms/asset/0da01b2c-0356-408d-9b4f-29403a2544e3/kbie_a_1987082_f0006_b.gif)
Availability of data and material
All data, models, and code generated or used during the study appear in the submitted article.